A resolution to designate May 4-10, 2025, as Tardive Dyskinesia Awareness Week.
Senate Resolution 30 designates May 4-10, 2025, as Tardive Dyskinesia Awareness Week. The resolution explains that tardive dyskinesia (TD) is a movement disorder associated with prolonged use of antipsychotic medications, and it highlights the importance of awareness, early screening, detection, and intervention. It also notes that people with serious mental illnesses such as bipolar disorder, major depressive disorder, and schizophrenia may use antipsychotic medications, and that certain groups—including older adults, Black individuals, women, and people with mood, substance use, or neurological conditions—face higher risk.
The resolution encourages health care providers, patients, and care partners to learn about TD screening and to follow clinical best practices, including routine screening recommended by the American Psychiatric Association. It also urges anyone experiencing uncontrollable, abnormal, repetitive movements to consult a health care provider. The measure is primarily commemorative and educational rather than regulatory, and it does not create new enforcement mechanisms or benefit programs.
SR 30 does not amend the Michigan Compiled Laws or create new statutory duties. Its legal effect is limited to a formal Senate designation of a public awareness week and a nonbinding encouragement of TD screening, consultation with providers, and education for clinicians, patients, and care partners. The practical impact is to elevate awareness of tardive dyskinesia among people taking antipsychotic medications and among health professionals who treat mental health conditions.
The overall sentiment appears strongly supportive and noncontroversial. The resolution is framed as a public health and patient-awareness measure, emphasizing the harms of underdiagnosis and the value of routine screening and FDA-approved treatments. No committee debate or recorded votes were provided, and the available text suggests broad bipartisan or at least consensus-oriented support for recognizing TD Awareness Week.
No explicit points of contention are identified in the available materials. If any concerns were to arise, they would likely center on the resolution’s emphasis on antipsychotic prescribing and screening practices, or on the broader implications of mental health treatment and diagnosis. However, the bill text itself is advisory and awareness-focused, and there is no evidence in the provided record of opposition, amendments, or disputed provisions.